Highland Capital Cuts Stake in PDL BioPharma (PDLI) to 6.9%
Tweet Send to a Friend
In a 13D filing on PDL BioPharma (Nasdaq: PDLI), Highland Capital Management ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
